MAM
Creative Galileo appoints Manish Doshi as Chief Operating Officer
Edtech platform brings in education veteran to drive next phase of growth.
MUMBAI: Creative Galileo has just found the perfect formula to accelerate its growth by bringing in a man who has spent over two decades helping shape the future of learning. The leading early learning and edtech platform today announced the appointment of Manish Doshi as its new Chief Operating Officer (COO). Doshi brings more than 20 years of rich experience across the global education ecosystem, including over 18 years with Cambridge University Press & Assessment and a stint with Oxford University Press.
In his new role, Manish will oversee operations as Creative Galileo continues to expand its presence across homes, classrooms, and institutional learning ecosystems in India and international markets.
Creative Galileo founder Prerna Jhunjhunwala said, “I’m pleased to welcome Manish Doshi as chief operating officer. As we expand our learning platforms across both local and global boards, Manish will help drive the next phase of growth and strengthen our engagement with schools, teachers and families.”
The appointment comes at a key moment in the company’s journey as it aims to make high-quality, engaging early learning accessible to millions of children while deepening partnerships with educational institutions worldwide.
From Cambridge to Creative Galileo, Manish Doshi has clearly mastered the art of building strong foundations and now he’s ready to help shape the next chapter of one of India’s promising early learning platforms.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
